Chloe Ramirez
The polio vaccine was first administered in 1955 by Dr. Jonas Salk, who inoculated 137 students at Arsenal Elementary School in Pittsburgh. The first polio vaccine was an inactive poliovirus injected with a syringe. Later, Dr. Albert Sabin of the Children's Hospital Research Foundation in Cincinnati, Ohio, discovered a new way to vaccinate children against polio: a weakened version of the live virus administered orally via a sugar cube. This method was used in the late 1950s, saving tens of millions of children from the disease. By 1979, polio was eradicated in the United States, thanks to the efforts of these pioneers in medicine.
| Characteristics | Values |
|---|---|
| Year of first polio vaccine | 1955 |
| Name of the doctor who created the first polio vaccine | Dr. Jonas Salk |
| University affiliated with the doctor who created the first polio vaccine | University of Pittsburgh |
| Type of vaccine | Inactive poliovirus |
| Number of students inoculated at Arsenal Elementary School in Pittsburgh | 137 |
| Year of inoculation at Arsenal Elementary School in Pittsburgh | 1954 |
| Name of the doctor who created the sugar cube vaccine | Dr. Albert Sabin |
| Hospital affiliated with Dr. Albert Sabin | Children's Hospital Research Foundation in Cincinnati, Ohio |
| Type of sugar cube vaccine | Weakened version of the live virus |
| Ease of administration | High |
| Type of vaccine | Oral |
| Time period of sugar cube vaccine | Late 1950s |
Explore related products
What You'll Learn
- The first polio vaccine was created in 1955 by Dr. Jonas Salk
- Dr Albert Sabin developed an oral polio vaccine, administered via sugar cubes
- The sugar cube vaccine was distributed in schools, churches, and fire stations
- Polio was contracted through exposure to contaminated water
- The polio vaccine has saved tens of millions of people
The first polio vaccine was created in 1955 by Dr. Jonas Salk
In the late 19th and early 20th centuries, polio was the most feared disease globally due to frequent epidemics. By the mid-20th century, the poliovirus had spread worldwide, killing or paralysing over half a million people annually. With no cure for the disease and epidemics on the rise, there was an urgent need for a vaccine.
In 1947, Jonas Salk, an American virologist and medical researcher, accepted a professorship at the University of Pittsburgh School of Medicine. There, he began a project to determine the number of different types of poliovirus. For the next seven years, Salk dedicated himself to developing a vaccine against polio.
In 1954, Salk tested his experimental "killed-virus" vaccine on himself, his family, and about one million children, known as the polio pioneers. The results were announced on April 12, 1955: the vaccine was safe and effective. Salk's inactivated polio vaccine (IPV) was licensed on the same day.
Salk's vaccine was composed of an inactive poliovirus administered by injection. He chose not to patent the vaccine or seek any profit from it, preferring it to be distributed as widely as possible. By 1957, annual polio cases in the US had dropped from 58,000 to 5,600, and by 1961, only 161 cases remained. Less than 25 years after the release of Salk's vaccine, domestic transmission of polio had been eliminated in the United States.
The oral polio vaccine (OPV), which was administered using a sugar cube, was developed by physician and microbiologist Albert Sabin. This vaccine used a weakened form of the live virus and was commercially available from 1961.
Blue Cross Blue Shield Illinois: Understanding Your Vaccine Coverage
You may want to see also
Explore related products
Dr Albert Sabin developed an oral polio vaccine, administered via sugar cubes
In the 20th century, polio was a dreaded disease that affected millions of people, particularly children. During the first half of the century, polio outbreaks occurred during the hot season, with thousands of children and adults falling victim to the virus. The severely affected were left paralysed, deformed, and unable to breathe without an iron lung.
In 1955, Dr Jonas Salk created the first polio vaccine, an inactive poliovirus administered via injection. However, this vaccine was not without its issues, as evidenced by the Cutter incident in 1955, where defective vaccine lots caused 192 cases of paralytic polio and 11 deaths. Thus, the search for alternative vaccines continued.
Dr Albert Sabin, a Polish-American medical researcher, developed an oral polio vaccine (OPV) that played a pivotal role in nearly eradicating the disease. Sabin's vaccine used a weakened version of the live virus, making it suitable for oral administration. This method of vaccination was quick and easy, requiring only a small drop of the vaccine to be placed on a sugar cube.
Sabin's approach was unique, as he aimed to create a live attenuated vaccine. He believed that an oral vaccine would offer superior protection compared to injections as they would be easier to administer. Sabin's dedication to his work extended beyond the laboratory, as he even tested his vaccine on himself, his family, and colleagues. Sabin's first oral poliovirus vaccine for type 1 polioviruses was licensed in the United States in 1961, with subsequent vaccines for types 2 and 3 licensed in 1962.
The Sabin vaccine became the primary method of vaccination against polio in the United States for three decades. It effectively broke the chain of virus transmission, paving the way for the potential eradication of polio. Sabin's refusal to patent his vaccine ensured its widespread accessibility, prioritising public health over commercial gain. The legacy of his work is honoured through the Sabin Vaccine Institute and the annual Albert B. Sabin Gold Medal award, recognising outstanding contributions in vaccinology.
Writing Religious Exemption for Vaccines in Pennsylvania
You may want to see also
Explore related products
The sugar cube vaccine was distributed in schools, churches, and fire stations
The sugar cube vaccine, also known as the Sabin vaccine, was developed by Dr. Albert Sabin of the Children's Hospital Research Foundation in Cincinnati, Ohio. It was a groundbreaking innovation in the fight against polio, a disease that predominantly affected children and was contracted through exposure to contaminated water.
Dr. Sabin's vaccine used a weakened version of the live poliovirus, which could be administered orally. This method proved to be a game-changer for vaccine distribution. The sugar cube vaccine was easy to administer and well-received by children, who found it more enjoyable than the traditional injection method.
The sugar cube vaccine was distributed in various community settings, including schools, churches, and fire stations. These locations served as convenient gathering places for parents eager to protect their children from polio. The oral nature of the vaccine allowed for quick and efficient administration, making it possible to immunize large numbers of children in a short period.
One memorable account of the sugar cube vaccine distribution comes from a former student who recalled their experience in the late 1950s. They described the process of lining up with their classmates, each receiving a sugar cube on a napkin. The school nurse instructed them to place the sugar cube in their mouths and let it dissolve, explaining that it was the miracle polio vaccine.
The sugar cube vaccine played a pivotal role in eradicating polio in the United States by 1979. It is estimated that tens of millions of lives were saved through this innovative vaccination program, offering a convenient and effective way to protect children from a terrifying disease.
Vaccine Refusal: Do I Need to Sign a Form?
You may want to see also
Explore related products
Polio was contracted through exposure to contaminated water
Polio is a highly contagious and life-threatening disease that can affect people of any age, but it mainly targets children under five years old. The poliovirus can infect the brain and spinal cord, leading to paralysis, permanent disability, and even death. It is transmitted through contact with the faecal matter of an infected person, often via contaminated water or food. In the past, children were sometimes isolated from their families and treated in hospitals to prevent the spread of the disease.
The poliovirus spreads rapidly and easily, and it often does not cause any symptoms or only mild symptoms, making it challenging to detect. However, even those without symptoms can spread the virus to others. The virus enters the body through the mouth and can contaminate food and water in unsanitary conditions. It can also spread through close contact with an infected person, such as by sharing food or utensils, or through cough or sneeze droplets.
The development of polio vaccines has been instrumental in combating the disease. In 1955, Dr Jonas Salk created the first polio vaccine, an inactive poliovirus administered by injection. Soon after, Dr Albert Sabin introduced a new oral vaccine using a weakened version of the live virus. This vaccine was dropped onto sugar cubes, making it quick and easy to administer to children. The sugar cube vaccine played a significant role in eradicating polio, and it remains a memorable part of vaccination history for many.
While polio has been virtually eradicated globally due to vaccination efforts, it has not been completely eliminated. Cases of wild poliovirus have decreased by over 99% since 1988, but the disease still occurs in certain parts of the world. Maintaining high immunity through vaccination is crucial to protect people from polio and prevent its resurgence. The polio vaccine is safe and effective, and it can provide 99-100% protection against the disease. However, as long as a single child remains infected, the risk of polio persists.
Vaccination: Mark of the Beast or Public Health?
You may want to see also
Explore related products
$5.99
The polio vaccine has saved tens of millions of people
In 1949, a breakthrough occurred when poliovirus was successfully cultivated in human tissue by John Enders, Thomas Weller, and Frederick Robbins at Boston Children's Hospital. Their pioneering work paved the way for the creation of the first successful vaccine by US physician Jonas Salk in the early 1950s. Salk's inactivated polio vaccine (IPV) was licensed on 12 April 1955, the same day the results were announced. This vaccine was administered by injection.
Dr Albert Sabin introduced an oral polio vaccine (OPV) that was easier to administer and had lower production costs. This vaccine was tested on more than 100 million people in the Soviet Union before obtaining its license in 1961. The OPV played a crucial role in mass vaccination campaigns, with Hungary becoming the first country to use it in December 1959, followed by Czechoslovakia in early 1960, becoming the first country to eliminate polio.
The global fight against polio has made significant progress, with two of the three types of wild poliovirus eradicated worldwide. The number of cases has drastically reduced from an estimated 350,000 in 1988 to 33 in 2018, thanks to the development and distribution of polio vaccines. The World Health Organization's (WHO) recommendation for universal childhood vaccination against polio has been instrumental in this achievement. The contributions of Dr Salk and Dr Sabin will forever be remembered in the eradication of polio.
How Antibody Production Can Be Stimulated
You may want to see also
